Cornfield Dennis, Liu Zach, Gorczyca Wojciech, Weisberger James
Section of Hematopathology, Health Network Laboratories/Lehigh Valley Hospital, Allentown, Pa 18103, USA.
Arch Pathol Lab Med. 2003 Apr;127(4):461-4. doi: 10.5858/2003-127-0461-TPROFC.
Virtually no information exists in the medical literature on the immunophenotyping of small cell carcinoma by flow cytometry. CD56, or neural cell adhesion molecule, is widely expressed by small cell carcinoma and easily measured by flow cytometry.
To determine the potential usefulness of flow cytometry in the diagnosis of small cell carcinoma.
Retrospective data and archival material on 27 patients were obtained from community hospitals. Specimens (needle aspirations and tissue biopsies) from all patients demonstrated cytomorphologic and flow cytometric features consistent with small cell carcinoma. All measurements were performed at a large reference laboratory. Routine 3- and 4-color flow cytometry using a lymphoma antibody panel, including anti-CD56, was performed. Anti-cytokeratin antibody was also used in the last 12 cases. Immunohistochemical staining with a panel of conventional markers for neuroendocrine neoplasms was performed on available tissue for purposes of confirmation of small cell carcinoma.
Twenty-seven patients whose tissue specimens showed a clearly defined population of CD45-CD56+ cells by flow cytometry and cytomorphologic features consistent with small cell carcinoma.
Needle aspiration (n = 3) and tissue biopsy (n = 24) from a variety of sites.
CD56 positivity by flow cytometry was 100 to 1000 times that of the matched isotype control in 25 cases and 10 to 100 times that of the control in 2 cases. Cytokeratin positivity by flow cytometry was found in 12 of 12 cases. Immunohistochemical staining showed positivity for at least 1 cytokeratin and 1 or more neuroendocrine markers in 26 of 27 cases and confirmed the diagnosis of small cell carcinoma.
Routine flow cytometry can identify a neuroendocrine phenotype that shows a strong correlation with confirmatory immunohistochemical markers in cases exhibiting cytomorphologic features of small cell carcinoma. Flow cytometry appears to complement and may possibly be a satisfactory alternative to immunohistochemical staining when small cell carcinoma is suspected.
医学文献中几乎没有关于通过流式细胞术对小细胞癌进行免疫表型分析的信息。CD56,即神经细胞黏附分子,在小细胞癌中广泛表达,且易于通过流式细胞术检测。
确定流式细胞术在小细胞癌诊断中的潜在用途。
从社区医院获取了27例患者的回顾性数据和存档材料。所有患者的标本(针吸活检和组织活检)均显示出与小细胞癌一致的细胞形态学和流式细胞术特征。所有检测均在一家大型参考实验室进行。使用包括抗CD56在内的淋巴瘤抗体组合进行常规三色和四色流式细胞术检测。在最后12例病例中还使用了抗细胞角蛋白抗体。为确认小细胞癌,对可用组织进行了一组神经内分泌肿瘤常规标志物的免疫组织化学染色。
27例患者的组织标本通过流式细胞术显示出明确的CD45-CD56+细胞群,且细胞形态学特征与小细胞癌一致。
从多个部位进行针吸活检(n = 3)和组织活检(n = 24)。
25例患者通过流式细胞术检测的CD56阳性率是匹配的同型对照的100至1000倍,2例患者是对照的10至100倍。12例病例中有12例通过流式细胞术检测到细胞角蛋白阳性。免疫组织化学染色显示,27例病例中有26例至少对1种细胞角蛋白和1种或更多神经内分泌标志物呈阳性,从而确诊为小细胞癌。
在表现出小细胞癌细胞形态学特征的病例中,常规流式细胞术可识别出一种神经内分泌表型,该表型与确证性免疫组织化学标志物显示出强烈相关性。当怀疑为小细胞癌时,流式细胞术似乎可作为免疫组织化学染色的补充,甚至可能是一种令人满意的替代方法。